FDA Prepares Rules for Psychedelic Medicine as Experts Demand Affordable Patient Care

Washington, Wednesday, 9 September 2026.
As the FDA establishes frameworks for therapeutic psychedelics, experts caution that overly restrictive research protocols could make real-world medical treatments prohibitively expensive for most patients.